Cargando…

What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature

Background: Neuroendocrine neoplasms (NEN) originate from neuroendocrine cells ubiquitously spread throughout the body. Hypercalcemia associated with cancer is the most common life-threatening metabolic disorder in patients with advanced stage cancer. Paraneoplastic hypercalcemia is more commonly as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giannetta, Elisa, Sesti, Franz, Modica, Roberta, Grossrubatscher, Erika Maria, Ragni, Alberto, Zanata, Isabella, Colao, Annamaria, Faggiano, Antongiulio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604936/ https://www.ncbi.nlm.nih.gov/pubmed/36294693 http://dx.doi.org/10.3390/jpm12101553

Ejemplares similares

Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers
por: Giannetta, Elisa, et al.
Publicado: (2021)

Gastric Neuroendocrine Tumors (g-NETs): A Systematic Review of the Management and Outcomes of Type 3 g-NETs
por: Laffi, Alice, et al.
Publicado: (2023)

Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches
por: Lania, Andrea, et al.
Publicado: (2021)

Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review
por: La Salvia, Anna, et al.
Publicado: (2021)

Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
por: Giannetta, Elisa, et al.
Publicado: (2021)

Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
por: Modica, Roberta, et al.
Publicado: (2022)

Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy
por: Grossrubatscher, Erika, et al.
Publicado: (2020)

Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
por: Fanciulli, Giuseppe, et al.
Publicado: (2022)

Neuroendocrine Carcinomas with Atypical Proliferation Index and Clinical Behavior: A Systematic Review
por: Feola, Tiziana, et al.
Publicado: (2021)

Editorial—Special Issue: Foreword to the Special Issue on NIKE: Neuroendocrine Tumors, Innovation in Knowledge and Education
por: Faggiano, Antongiulio, et al.
Publicado: (2021)

Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management
por: Altieri, Barbara, et al.
Publicado: (2019)

Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
por: Vitale, Giovanni, et al.
Publicado: (2021)

Foreword to the special issue on advances in neuroendocrine neoplasms
por: Vitale, Giovanni, et al.
Publicado: (2021)

Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues
por: Gallo, Marco, et al.
Publicado: (2021)

Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?
por: Barrea, Luigi, et al.
Publicado: (2021)

Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family
por: Puliani, Giulia, et al.
Publicado: (2020)

From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?
por: Vitale, Giovanni, et al.
Publicado: (2020)

Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask
por: Albertelli, Manuela, et al.
Publicado: (2021)

Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors
por: Barrea, Luigi, et al.
Publicado: (2021)

Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies
por: Vitale, Giovanni, et al.
Publicado: (2023)

Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual Function
por: Zamponi, Virginia, et al.
Publicado: (2022)

Management of Functional Pancreatic Neuroendocrine Neoplasms
por: Magi, Ludovica, et al.
Publicado: (2023)

Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?
por: Fanciulli, Giuseppe, et al.
Publicado: (2023)

Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study
por: Modica, R., et al.
Publicado: (2022)

The Effects of Radioligand Therapy on Quality of Life and Sexual Function in Patients with Neuroendocrine Neoplasms
por: Malandrino, Pasqualino, et al.
Publicado: (2022)

Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors
por: Altieri, Barbara, et al.
Publicado: (2020)

Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature
por: Feola, Tiziana, et al.
Publicado: (2020)

Prognostic significance of laterality in lung neuroendocrine tumors
por: La Salvia, Anna, et al.
Publicado: (2022)

A Novel MAX Gene Mutation Variant in a Patient With Multiple and “Composite” Neuroendocrine–Neuroblastic Tumors
por: Pozza, Carlotta, et al.
Publicado: (2020)

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness
por: Barrea, Luigi, et al.
Publicado: (2018)

Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms
por: Daskalakis, Kosmas, et al.
Publicado: (2018)

Diabetes and Cancer
por: Colao, Annamaria, et al.
Publicado: (2011)

Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
por: Muscogiuri, Giovanna, et al.
Publicado: (2022)

Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumors
por: Campolo, Federica, et al.
Publicado: (2023)

Hepatic arterial embolization in patients with neuroendocrine tumors
por: Del Prete, Michela, et al.
Publicado: (2014)

Primary Colonic Lymphoma With Paraneoplastic Hypercalcemia
por: Augustine, Thomas, et al.
Publicado: (2020)

Vitamin D and Cancer
por: Vuolo, Laura, et al.
Publicado: (2012)

Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs): A Systematic Review and Pooled Analysis
por: Arrivi, Giulia, et al.
Publicado: (2022)

Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead
por: Colao, Annamaria, et al.
Publicado: (2020)

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms
por: Tafuto, Salvatore, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o2tpf10rnnjsbn27vrpp6vlifn